Discovery of a Fluoroquinolone-Resistant Serratia marcescens Clinical Isolate without Quinolone Resistance-Determining Region Mutations
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Sir, Serratia marcescens , once considered to be an innocuous and non-pathogenic organism, is now an important cause of hospital- acquired infections. This organism is associated with respiratory tract infections, urinary tract infections, septicemia, meningitis, and wound infections [1, 2]. S. marcescens infections are difficult to treat because of high resistance to a wide variety of antibiotics, including cephalosporins, fluoroquinolones, and aztreonam [2].
Abstract
Sir, Serratia marcescens , once considered to be an innocuous and non-pathogenic organism, is now an important cause of hospital- acquired infections. This organism is associated with respiratory tract infections, urinary tract infections, septicemia, meningitis, and wound infections [1, 2]. S. marcescens infections are difficult to treat because of high resistance to a wide variety of antibiotics, including cephalosporins, fluoroquinolones, and aztreonam [2].
참고문헌 (8)
- Mahlen SD, "Serratia infections: from military experiments to current practice", Clin Microbiol Rev, 24, pp.755~791 (2011)
- Yang HF, "Plasmid-mediated quinolone resistance in extended-spectrum-β-lactamase- and AmpC β-lactamaseproducing Serratia marcescens in China", Antimicrob Agents Chemother, 56, pp.4529~4531 (2012)
- Ruiz J, "Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection", J Antimicrob Chemother, 51, pp.1109~1117 (2003)
- Strahilevitz J, "Plasmid-mediated quinolone resistance: a multifaceted threat", Clin Microbiol Rev, 22, pp.664~689 (2009)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing, Twenty-Second Informational supplement, M100-S22" (2012), CLSI
- Ruiz J, "Transferable mechanisms of quinolone resistance", Int J Antimicrob Agents, 40, pp.196~203 (2012)
- Sato T, "A fluoroquinolone-resistant Escherichia coli clinical isolate without quinolone resistance-determining region mutations found in Japan", Antimicrob Agents Chemother, 55, pp.3964~3965 (2011)
- Chopra S, "A fluoroquinolone-resistant Acinetobacter baumannii without the quinolone resistance-determining region mutations", J Antimicrob Chemother, 66, pp.2668~2670 (2011)